The Journal of Immunology, Vol 143, Issue 4 1295-1302, Copyright © 1989 by American Association of Immunologists

ARTICLES

Mechanism of arachidonic acid liberation in platelet-activating factor- stimulated human polymorphonuclear neutrophils

S Nakashima, A Suganuma, M Sato, T Tohmatsu and Y Nozawa
Department of Biochemistry, Gifu University School of Medicine, Japan.

Upon stimulation of human polymorphonuclear neutrophils with platelet- activating factor (PAF), arachidonic acid (AA) is released from membrane phospholipids. The mechanism for AA liberation, a key step in the synthesis of biologically active eicosanoids, was investigated. PAF was found to elicit an increase in the cytoplasmic level of free Ca2+ as monitored by fluorescent indicator fura 2. When [3H] AA-labeled neutrophils were exposed to PAF, the enhanced release of AA was observed with a concomitant decrease of radioactivity in phosphatidylinositol and phosphatidylcholine fractions. The inhibitors of phospholipase A2, mepacrine and 2-(p-amylcinnamoyl)-amino-4- chlorobenzoic acid, effectively suppressed the liberation of [3H]AA from phospholipids, indicating that liberation of AA is mainly catalyzed by the action of phospholipase A2. The extracellular Ca2+ is not required for AA release. However, intracellular Ca2+ antagonists, TMB-8 and high dose of quin 2/AM drastically reduced the liberation of AA induced by PAF, indicating that Ca2+ is an essential factor for phospholipase A2 activation. PAF raised the fluorescence of fura 2 at concentrations as low as 8 pM which reached a maximal level about 8 nM, whereas more than nM order concentrations of PAF was required for the detectable release of [3H]AA. Pretreatment of neutrophils with pertussis toxin resulted in complete abolition of AA liberation in response to PAF. However, the fura 2 response to PAF was not effectively inhibited by toxin treatment. In human neutrophil homogenate and membrane preparations, guanosine 5'-O-(thiotriphosphate) stimulated AA release and potentiated the action of PAF. Guanosine 5'-O- (thiodiphosphate) inhibited the effects of guanosine 5'-O- (thiotriphosphate). These results suggest several points: 1) PAF stimulates human polymorphonuclear neutrophils to liberate AA mainly by the action of phospholipase A2; 2) Ca2+ mobilization alone is not sufficient to stimulate AA release, although Ca2+ is the important factor for phospholipase A2 activation; and 3) a pertussis toxin- sensitive GTP-binding protein may be implicated in activation of phospholipase A2.

This article has been cited by other articles:

				T. E. Decoursey Voltage-Gated Proton Channels and Other Proton Transfer Pathways Physiol Rev, April 1, 2003; 83(2): 475 - 579. [Abstract] [Full Text] [PDF]

				X. Zhao, E. A. Bey, F. B. Wientjes, and M. K. Cathcart Cytosolic Phospholipase A2 (cPLA2) Regulation of Human Monocyte NADPH Oxidase Activity. cPLA2 AFFECTS TRANSLOCATION BUT NOT PHOSPHORYLATION OF p67phox AND p47phox J. Biol. Chem., July 5, 2002; 277(28): 25385 - 25392. [Abstract] [Full Text] [PDF]

				G. Montrucchio, G. Alloatti, and G. Camussi Role of Platelet-Activating Factor in Cardiovascular Pathophysiology Physiol Rev, October 1, 2000; 80(4): 1669 - 1699. [Abstract] [Full Text] [PDF]

				R. Dana, T. L. Leto, H. L. Malech, and R. Levy Essential Requirement of Cytosolic Phospholipase A2 for Activation of the Phagocyte NADPH Oxidase J. Biol. Chem., January 2, 1998; 273(1): 441 - 445. [Abstract] [Full Text] [PDF]

				S. A. Carlson, T. K. Chatterjee, and R. A. Fisher The Third Intracellular Domain of the Platelet-activating Factor Receptor Is a Critical Determinant in Receptor Coupling to Phosphoinositide Phospholipase C-activating G Proteins. STUDIES USING INTRACELLULAR DOMAIN MINIGENES AND RECEPTOR CHIMERAS J. Biol. Chem., September 20, 1996; 271(38): 23146 - 23153. [Abstract] [Full Text] [PDF]